Shahrokhi, S., Daneshmandi, S., & Menaa, F. (2014). Tumor Necrosis Factor-α/CD40 Ligand-Engineered Mesenchymal Stem Cells Greatly Enhanced the Antitumor Immune Response and Lifespan in Mice. Mary Ann Liebert, Inc.
استشهاد بنمط شيكاغوShahrokhi, Somayeh, Saeed Daneshmandi, و Farid Menaa. Tumor Necrosis Factor-α/CD40 Ligand-Engineered Mesenchymal Stem Cells Greatly Enhanced the Antitumor Immune Response and Lifespan in Mice. Mary Ann Liebert, Inc, 2014.
MLA استشهادShahrokhi, Somayeh, Saeed Daneshmandi, و Farid Menaa. Tumor Necrosis Factor-α/CD40 Ligand-Engineered Mesenchymal Stem Cells Greatly Enhanced the Antitumor Immune Response and Lifespan in Mice. Mary Ann Liebert, Inc, 2014.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.